Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HYbrid CoronAry Revascularization in DiabeticS: A Randomized Controlled Trial (Pilot)

NCT02504762 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.

NCT NCT02504762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02504762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HYbrid CoronAry Revascularization in DiabeticS: A Randomized Controlled Trial (Pilot)
Lead sponsor
Ottawa Heart Institute Research Corporation
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2015
Completion date
December 31, 2019
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, heart disease